Product NDC: | 39822-0166 |
Proprietary Name: | Polymyxin B |
Non Proprietary Name: | Polymyxin B |
Active Ingredient(s): | 500000 [USP'U]/1 & nbsp; Polymyxin B |
Administration Route(s): | INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 39822-0166 |
Labeler Name: | X-GEN Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063000 |
Marketing Category: | ANDA |
Start Marketing Date: | 19940930 |
Package NDC: | 39822-0166-5 |
Package Description: | 1 VIAL in 1 CARTON (39822-0166-5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Code | 39822-0166-5 |
Proprietary Name | Polymyxin B |
Package Description | 1 VIAL in 1 CARTON (39822-0166-5) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Product NDC | 39822-0166 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Polymyxin B |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC |
Start Marketing Date | 19940930 |
Marketing Category Name | ANDA |
Labeler Name | X-GEN Pharmaceuticals, Inc. |
Substance Name | POLYMYXIN B SULFATE |
Strength Number | 500000 |
Strength Unit | [USP'U]/1 |
Pharmaceutical Classes | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] |